Described herein are pharmaceutical packaging systems which prevent oxidative degradation of morphine, hydromorphone, promethazine and also other oxygen-delicate prescription drugs, such systems such as a syringe using an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with quite reduced permeability to oxyge